Lung microbiota: a new hope for treating acute respiratory distress syndrome?

The lung microbiota, present in healthy individuals, undergoes alterations in different diseases and is closely linked to changes in both systemic and alveolar immunity. These interactions play a crucial role in the onset and progression of numerous diseases. Acute respiratory distress syndrome (ARD...

Full description

Saved in:
Bibliographic Details
Main Authors: Yao Tang, Bo Liu, Aijia Ma, Bo Wang, Huaiyu Xiong, Yi Zhou, Jing Yang, Yan Kang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2025.1586949/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849717546465361920
author Yao Tang
Bo Liu
Aijia Ma
Bo Wang
Huaiyu Xiong
Yi Zhou
Jing Yang
Yan Kang
author_facet Yao Tang
Bo Liu
Aijia Ma
Bo Wang
Huaiyu Xiong
Yi Zhou
Jing Yang
Yan Kang
author_sort Yao Tang
collection DOAJ
description The lung microbiota, present in healthy individuals, undergoes alterations in different diseases and is closely linked to changes in both systemic and alveolar immunity. These interactions play a crucial role in the onset and progression of numerous diseases. Acute respiratory distress syndrome (ARDS), one of the most severe conditions encountered in intensive care units (ICU), is characterized by high incidence and mortality rates. The pathophysiology of ARDS involves complex mechanisms, including the activation and dysregulation of overlapping pathways related to injury, inflammation, and coagulation, both locally in the lungs and systemically. Notably, alterations in the microbiota may contribute to the pathogenesis of ARDS. Emerging evidence suggests that changes in the lung microbiota are associated with ARDS development, often marked by increased bacterial burden, reduced microbial diversity, and shifts in microbiota composition. In this review, we focus on the regulatory roles of the lung microbiota in ARDS and their therapeutic potential.
format Article
id doaj-art-20bcb31857a84d8bb8f2276c12e4aca2
institution DOAJ
issn 1664-302X
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj-art-20bcb31857a84d8bb8f2276c12e4aca22025-08-20T03:12:38ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2025-05-011610.3389/fmicb.2025.15869491586949Lung microbiota: a new hope for treating acute respiratory distress syndrome?Yao Tang0Bo Liu1Aijia Ma2Bo Wang3Huaiyu Xiong4Yi Zhou5Jing Yang6Yan Kang7Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, ChinaDepartment of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, ChinaDepartment of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, ChinaDepartment of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, ChinaDepartment of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, ChinaWest China Hospital, Institutes for Systems Genetics, Sichuan University, Chengdu, ChinaDepartment of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, ChinaDepartment of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, ChinaThe lung microbiota, present in healthy individuals, undergoes alterations in different diseases and is closely linked to changes in both systemic and alveolar immunity. These interactions play a crucial role in the onset and progression of numerous diseases. Acute respiratory distress syndrome (ARDS), one of the most severe conditions encountered in intensive care units (ICU), is characterized by high incidence and mortality rates. The pathophysiology of ARDS involves complex mechanisms, including the activation and dysregulation of overlapping pathways related to injury, inflammation, and coagulation, both locally in the lungs and systemically. Notably, alterations in the microbiota may contribute to the pathogenesis of ARDS. Emerging evidence suggests that changes in the lung microbiota are associated with ARDS development, often marked by increased bacterial burden, reduced microbial diversity, and shifts in microbiota composition. In this review, we focus on the regulatory roles of the lung microbiota in ARDS and their therapeutic potential.https://www.frontiersin.org/articles/10.3389/fmicb.2025.1586949/fulllung microbiotaARDScorona virus disease 2019 (COVID-19)prognosismetabolic products
spellingShingle Yao Tang
Bo Liu
Aijia Ma
Bo Wang
Huaiyu Xiong
Yi Zhou
Jing Yang
Yan Kang
Lung microbiota: a new hope for treating acute respiratory distress syndrome?
Frontiers in Microbiology
lung microbiota
ARDS
corona virus disease 2019 (COVID-19)
prognosis
metabolic products
title Lung microbiota: a new hope for treating acute respiratory distress syndrome?
title_full Lung microbiota: a new hope for treating acute respiratory distress syndrome?
title_fullStr Lung microbiota: a new hope for treating acute respiratory distress syndrome?
title_full_unstemmed Lung microbiota: a new hope for treating acute respiratory distress syndrome?
title_short Lung microbiota: a new hope for treating acute respiratory distress syndrome?
title_sort lung microbiota a new hope for treating acute respiratory distress syndrome
topic lung microbiota
ARDS
corona virus disease 2019 (COVID-19)
prognosis
metabolic products
url https://www.frontiersin.org/articles/10.3389/fmicb.2025.1586949/full
work_keys_str_mv AT yaotang lungmicrobiotaanewhopefortreatingacuterespiratorydistresssyndrome
AT boliu lungmicrobiotaanewhopefortreatingacuterespiratorydistresssyndrome
AT aijiama lungmicrobiotaanewhopefortreatingacuterespiratorydistresssyndrome
AT bowang lungmicrobiotaanewhopefortreatingacuterespiratorydistresssyndrome
AT huaiyuxiong lungmicrobiotaanewhopefortreatingacuterespiratorydistresssyndrome
AT yizhou lungmicrobiotaanewhopefortreatingacuterespiratorydistresssyndrome
AT jingyang lungmicrobiotaanewhopefortreatingacuterespiratorydistresssyndrome
AT yankang lungmicrobiotaanewhopefortreatingacuterespiratorydistresssyndrome